Home/ Stocks/ WHWK

Whitehawk Therapeutics, Inc. Common Stock

WHWK XNAS

$4.76 -0.03 (-0.64%) ▼ 15-min delayed

Open

$4.69

High

$4.88

Low

$4.59

Volume

600.1K

Market Cap

$232.43M

About Whitehawk Therapeutics, Inc. Common Stock

Whitehawk Therapeutics Inc is an oncology therapeutics company applying technologies to tumor biology to develop cancer treatments. Its portfolio includes three antibody-drug conjugate (ADC) candidates designed to address limitations of earlier therapies for patients with difficult-to-treat cancers. The company generates revenue from the sale of its products.

Sector: PHARMACEUTICAL PREPARATIONS Employees: 23 Website →

Key Financials

Period	Revenue	Net Income	EPS
Q1 2026	$0	$-22,194,000	$-0.32
FY 2025	$7.14M	$-20,596,000	$-0.33
Q3 2025	$0	$-17,746,000	$-0.26
Q2 2025	$0	$-52,615,000	$-0.76

Earnings & Analyst Ratings

Next Earnings: Wed, Nov 4, 2026

Calendar →

Related Market News

No specific coverage for WHWK yet. Check out our latest market news or earnings calendar.

Get WHWK Alerts

Stay ahead with breaking news, price alerts, and expert analysis on Whitehawk Therapeutics, Inc. Common Stock.

Disclaimer: This page is for informational purposes only. Stock data is delayed by at least 15 minutes. Always conduct your own research and consult with a qualified financial advisor before making investment decisions.